Download presentation
Presentation is loading. Please wait.
1
Presented By Sham Mailankody at 2016 ASCO Annual Meeting
Genetic plasma cell signatures in high-risk smoldering myeloma versus multiple myeloma patients Presented By Sham Mailankody at 2016 ASCO Annual Meeting
2
Massive genetic heterogeneity in <br />multiple myeloma
Presented By Sham Mailankody at 2016 ASCO Annual Meeting
3
Multiple myeloma consistently preceded by precursor states
Presented By Sham Mailankody at 2016 ASCO Annual Meeting
4
Presented By Sham Mailankody at 2016 ASCO Annual Meeting
Slide 4 Presented By Sham Mailankody at 2016 ASCO Annual Meeting
5
Presented By Sham Mailankody at 2016 ASCO Annual Meeting
Slide 5 Presented By Sham Mailankody at 2016 ASCO Annual Meeting
6
Patients and treatment response
Presented By Sham Mailankody at 2016 ASCO Annual Meeting
7
Samples and bioinformatic analysis
Presented By Sham Mailankody at 2016 ASCO Annual Meeting
8
Samples and bioinformatic analysis
Presented By Sham Mailankody at 2016 ASCO Annual Meeting
9
Presented By Sham Mailankody at 2016 ASCO Annual Meeting
Slide 9 Presented By Sham Mailankody at 2016 ASCO Annual Meeting
10
Presented By Sham Mailankody at 2016 ASCO Annual Meeting
Slide 10 Presented By Sham Mailankody at 2016 ASCO Annual Meeting
11
Significantly recurrent mutations in multiple myeloma
Presented By Sham Mailankody at 2016 ASCO Annual Meeting
12
Presented By Sham Mailankody at 2016 ASCO Annual Meeting
Significantly recurrent mutations of individual genes in multiple myeloma Presented By Sham Mailankody at 2016 ASCO Annual Meeting
13
Presented By Sham Mailankody at 2016 ASCO Annual Meeting
Slide 13 Presented By Sham Mailankody at 2016 ASCO Annual Meeting
14
Presented By Sham Mailankody at 2016 ASCO Annual Meeting
Slide 14 Presented By Sham Mailankody at 2016 ASCO Annual Meeting
15
Presented By Sham Mailankody at 2016 ASCO Annual Meeting
Slide 15 Presented By Sham Mailankody at 2016 ASCO Annual Meeting
16
Presented By Sham Mailankody at 2016 ASCO Annual Meeting
Slide 16 Presented By Sham Mailankody at 2016 ASCO Annual Meeting
17
Significantly recurrent mutations in multiple myeloma
Presented By Sham Mailankody at 2016 ASCO Annual Meeting
18
Recurrent mutations in the NF-kB pathway
Presented By Sham Mailankody at 2016 ASCO Annual Meeting
19
Number of patients with mutations in the NF-kB pathway genes
Presented By Sham Mailankody at 2016 ASCO Annual Meeting
20
Presented By Sham Mailankody at 2016 ASCO Annual Meeting
Conclusions Presented By Sham Mailankody at 2016 ASCO Annual Meeting
21
Presented By Sham Mailankody at 2016 ASCO Annual Meeting
Conclusions (cont.) Presented By Sham Mailankody at 2016 ASCO Annual Meeting
22
Myeloma Program at MSKCC
Presented By Sham Mailankody at 2016 ASCO Annual Meeting
23
Presented By Sham Mailankody at 2016 ASCO Annual Meeting
Slide 23 Presented By Sham Mailankody at 2016 ASCO Annual Meeting
24
Thank you to our patients!
Presented By Sham Mailankody at 2016 ASCO Annual Meeting
Similar presentations
